Maria Angelica Ehara Watanabe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maria Angelica Ehara Watanabe has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Edna Maria Vissoci Reiche
Department of Pathology, Clinical Analysis, and Toxicology; Health Sciences Center, Londrina State University, Londrina, Paraná, Brazil
2 shared publications- Maria Helena Pelegrinelli Fungaro
Londrina State University, Londrina, PR, Brazil
2 shared publications Marla Karine Amarante
State University of Londrina
2 shared publications- Marla Karine Amarante
Department of Pathology, Clinical Analysis and Toxicology, Health Sciences Center, Londrina State University, Londrina, Brazil
2 shared publications Ana Cristina da Silva Do Amaral Herrera
State University of Londrina
1 shared publicationBruno Alberto Fabris
State University of Londrina
1 shared publication
Latest Publications
- 31 July 2009
- Published by Elsevier in Microbial Pathogenesis
- Vol. 47 (1) , 33-37
Detection of TT virus in HIV-1 exposed but uninfected individuals and in HIV-1 infected patients and its influence on CD4+ lymphocytes and viral load
- 31 July 2009
- Published by Elsevier in Microbial Pathogenesis
- Vol. 47 (1) , 33-37
Detection of TT virus in HIV-1 exposed but uninfected individuals and in HIV-1 infected patients and its influence on CD4+ lymphocytes and viral load
- 6 January 2009
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 135 (8) , 997-1004
Plasma malondialdehyde levels and CXCR4 expression in peripheral blood cells of breast cancer patients
Breast cancer is one of the most common neoplasms in women and is a leading cause of cancer related deaths worldwide. Chemokines and their receptors are involved in the control of lymphocyte traffic, a critical component of systemic immunity. CXCR4 mRNA could be involved in the development of variety of diseases. Lipid peroxidation, the result of nonenzymatic autooxidation of polyunsaturated fatty acids, presents numerous harmful effects on biological systems and has been implicated in diseases like cancer. This study examined CXCR4 mRNA expression in peripheral blood cells and malondialdehyde (MDA) in plasma from blood donors and breast cancer patients. CXCR4 expression in peripheral blood cells from 59 breast cancer patients and 76 healthy blood donors was analyzed by real-time PCR. Plasma MDA was analyzed using high-performance liquid chromatography (HPLC). In all stages, MDA levels in total breast cancer patients (1.41 ± 0.11) were significantly higher (P < 0.01) than those in healthy subjects (0.34 ± 0.03). No statistically significant difference occurred between CXCR4 expression in peripheral blood cells from breast cancer patients (1.69 ± 1.05) and the normal healthy control group (1.8 ± 0.65). However, stage II samples differed statistically (4.3 ± 1.72) from control, total cancer patients and stages I, III and IV samples.
- 6 January 2009
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 135 (8) , 997-1004
Plasma malondialdehyde levels and CXCR4 expression in peripheral blood cells of breast cancer patients
Breast cancer is one of the most common neoplasms in women and is a leading cause of cancer related deaths worldwide. Chemokines and their receptors are involved in the control of lymphocyte traffic, a critical component of systemic immunity. CXCR4 mRNA could be involved in the development of variety of diseases. Lipid peroxidation, the result of nonenzymatic autooxidation of polyunsaturated fatty acids, presents numerous harmful effects on biological systems and has been implicated in diseases like cancer. This study examined CXCR4 mRNA expression in peripheral blood cells and malondialdehyde (MDA) in plasma from blood donors and breast cancer patients. CXCR4 expression in peripheral blood cells from 59 breast cancer patients and 76 healthy blood donors was analyzed by real-time PCR. Plasma MDA was analyzed using high-performance liquid chromatography (HPLC). In all stages, MDA levels in total breast cancer patients (1.41 ± 0.11) were significantly higher (P < 0.01) than those in healthy subjects (0.34 ± 0.03). No statistically significant difference occurred between CXCR4 expression in peripheral blood cells from breast cancer patients (1.69 ± 1.05) and the normal healthy control group (1.8 ± 0.65). However, stage II samples differed statistically (4.3 ± 1.72) from control, total cancer patients and stages I, III and IV samples.
- 14 November 2008
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 135 (3) , 329-337
The possible involvement of virus in breast cancer
It is well known that the etiology of human breast cancer is significantly affected by environmental factors. Virus-associated cancer refers to a cancer where viral infection results in the malignant transformation of the host’s infected cells. Human papillomaviruses (HPV), mouse mammary tumor virus (MMTV) and Epstein–Barr (EBV) virus are prime candidate viruses as agents of human breast cancer. The precise role that viruses play in tumorigenesis is not clear, but it seems that they are responsible for causing only one in a series of steps required for cancer development. The idea that a virus could cause breast cancer has been investigated for quite some time, even though breast cancer could be a hereditary disease; however, hereditary breast cancer is estimated to account for a small percentage of all breast cancer cases. Based on current research, this review present at moment, substantial, but not conclusive, evidence that HPV, EBV and MMTV may be involved in breast cancer.
- 14 November 2008
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 135 (3) , 329-337
The possible involvement of virus in breast cancer
It is well known that the etiology of human breast cancer is significantly affected by environmental factors. Virus-associated cancer refers to a cancer where viral infection results in the malignant transformation of the host’s infected cells. Human papillomaviruses (HPV), mouse mammary tumor virus (MMTV) and Epstein–Barr (EBV) virus are prime candidate viruses as agents of human breast cancer. The precise role that viruses play in tumorigenesis is not clear, but it seems that they are responsible for causing only one in a series of steps required for cancer development. The idea that a virus could cause breast cancer has been investigated for quite some time, even though breast cancer could be a hereditary disease; however, hereditary breast cancer is estimated to account for a small percentage of all breast cancer cases. Based on current research, this review present at moment, substantial, but not conclusive, evidence that HPV, EBV and MMTV may be involved in breast cancer.
- Open Access
- 1 January 2008
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 22 (4) , 314-320
RNA from Borna disease virus in patients with schizophrenia, schizoaffective patients, and in their biological relatives
Numerous interactions of the immune system with the central nervous system have been described recently. Mood and psychotic disorders, such as severe depression and schizophrenia, are both heterogeneous disorders regarding clinical symptomatology, the acuity of symptoms, the clinical course, the treatment response, and probably also the etiology. Detection of p24 RNA from Borna disease virus (BDV) by the reverse transcriptase polymerase chain reaction in patients with schizophrenia, schizoaffective disorder, and in their biological relatives was evaluated. The subjects were 27 schizophrenic and schizoaffective patients, 27 healthy controls, 20 relatives without psychiatric disease, and 24 relatives with mood disorder, who attended the Psychiatric Ambulatory of Londrina State University, Paraná, Brazil. The subjects were interviewed by structured diagnostic criteria categorized according to the Diagnostic and Statistical Manual of Mental Disorders‐IV, axis I, (SCID‐IV). The mean duration of illness in schizophrenic and schizoaffective patients was 15.341±1.494 years and the median age at onset was 22.4±7.371 years. There were no significant differences in gender (P=0.297), age (P=0.99), albumin (P=0.26), and body mass index (kg/m2) (p=0.28), among patients, controls, and relatives. Patients and biological relatives had significantly higher positive p24 RNA BDV detection than controls (P=0.04); however, the clinical significance of BDV remains to be clarified. J. Clin. Lab. Anal. 22:314–320, 2008.
- 1 January 2008
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 22 (4) , 314-320
Open AccessRNA from Borna disease virus in patients with schizophrenia, schizoaffective patients, and in their biological relatives
Numerous interactions of the immune system with the central nervous system have been described recently. Mood and psychotic disorders, such as severe depression and schizophrenia, are both heterogeneous disorders regarding clinical symptomatology, the acuity of symptoms, the clinical course, the treatment response, and probably also the etiology. Detection of p24 RNA from Borna disease virus (BDV) by the reverse transcriptase polymerase chain reaction in patients with schizophrenia, schizoaffective disorder, and in their biological relatives was evaluated. The subjects were 27 schizophrenic and schizoaffective patients, 27 healthy controls, 20 relatives without psychiatric disease, and 24 relatives with mood disorder, who attended the Psychiatric Ambulatory of Londrina State University, Paraná, Brazil. The subjects were interviewed by structured diagnostic criteria categorized according to the Diagnostic and Statistical Manual of Mental Disorders‐IV, axis I, (SCID‐IV). The mean duration of illness in schizophrenic and schizoaffective patients was 15.341±1.494 years and the median age at onset was 22.4±7.371 years. There were no significant differences in gender (P=0.297), age (P=0.99), albumin (P=0.26), and body mass index (kg/m2) (p=0.28), among patients, controls, and relatives. Patients and biological relatives had significantly higher positive p24 RNA BDV detection than controls (P=0.04); however, the clinical significance of BDV remains to be clarified. J. Clin. Lab. Anal. 22:314–320, 2008.
- 24 June 2003
- Published by Elsevier in Microbial Pathogenesis
- Vol. 35 (1) , 31-34
SDF-1 gene polymorphisms and syncytia induction in Brazilian HIV-1 infected individuals
- 24 June 2003
- Published by Elsevier in Microbial Pathogenesis
- Vol. 35 (1) , 31-34
SDF-1 gene polymorphisms and syncytia induction in Brazilian HIV-1 infected individuals